Skip to main content
Top
Published in: Inflammation 4/2016

Open Access 01-08-2016 | ORIGINAL ARTICLE

Susceptibility to Aspergillus Infections in Rats with Chronic Obstructive Pulmonary Disease via Deficiency Function of Alveolar Macrophages and Impaired Activation of TLR2

Authors: Yuting Wu, Hong Xu, Li Li, Weifeng Yuan, Deming Zhang, Wenjie Huang

Published in: Inflammation | Issue 4/2016

Login to get access

Abstract

Clinical evidence indicates that patients with severe chronic obstructive pulmonary disease (COPD) are more susceptible to Aspergillus. However, the exact mechanisms underlying this effect are not known. In this study, we used cigarette smoke exposure to generate COPD rat model. colony-forming units (CFU) count assessment and phagocytosis were applied to evaluate the defense function of COPD rats against Aspergillus challenge. ELISA, western blotting, and GST-Rac1 pull-down assays were conducted to determine the expressions of cytokines and TLR2-associated signaling pathway. Our data showed that Aspergillus burdens increased, phagocytosis of Aspergillus as well as the expressions of inflammatory cytokines from alveolar macrophages (AMs) were impaired in COPD rats compared with normal rats. Though TLR2 signaling-related proteins were induced in response to the stimulation of Aspergillus or Pam3csk4 (TLR2 agonist), the activation of TLR2-associated signaling pathway was apparently interfered in rats with COPD, compared to that in normal rats. Taken together, our study demonstrated that COPD caused the deficiency of AMs function and impaired the activation of TLR2/PI3K/Rac 1 signaling pathway, leading to invasion of Aspergillus infection, which also provides a future basis for the infection control in COPD patients.
Literature
1.
go back to reference Garnacho-Montero, J., R. Amaya-Villar, C. Ortiz-Leyba, et al. 2005. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Critical Care (London, England) 9: R191–R199.CrossRef Garnacho-Montero, J., R. Amaya-Villar, C. Ortiz-Leyba, et al. 2005. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Critical Care (London, England) 9: R191–R199.CrossRef
2.
go back to reference Samarakoon, P., and A. Soubani. 2008. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chronic Respiratory Disease 5: 19–27.CrossRefPubMed Samarakoon, P., and A. Soubani. 2008. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chronic Respiratory Disease 5: 19–27.CrossRefPubMed
3.
go back to reference Xu, H., L. Li, W.J. Huang, L.X. Wang, W.F. Li, and W.F. Yuan. 2012. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 18: 403–408.CrossRef Xu, H., L. Li, W.J. Huang, L.X. Wang, W.F. Li, and W.F. Yuan. 2012. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 18: 403–408.CrossRef
4.
go back to reference Wasylnka, J.A., and M.M. Moore. 2002. Uptake of Aspergillus fumigatus conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. Infection and Immunity 70: 3156–3163.CrossRefPubMedPubMedCentral Wasylnka, J.A., and M.M. Moore. 2002. Uptake of Aspergillus fumigatus conidia by phagocytic and nonphagocytic cells in vitro: quantitation using strains expressing green fluorescent protein. Infection and Immunity 70: 3156–3163.CrossRefPubMedPubMedCentral
5.
go back to reference Marriott, H.M., and D.H. Dockrell. 2007. The role of the macrophage in lung disease mediated by bacteria. Experimental Lung Research 33: 493–505.CrossRefPubMed Marriott, H.M., and D.H. Dockrell. 2007. The role of the macrophage in lung disease mediated by bacteria. Experimental Lung Research 33: 493–505.CrossRefPubMed
6.
7.
go back to reference Lindberg, A., B. Eriksson, L.G. Larsson, E. Ronmark, T. Sandstrom, and B. Lundback. 2006. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 129: 879–885.CrossRefPubMed Lindberg, A., B. Eriksson, L.G. Larsson, E. Ronmark, T. Sandstrom, and B. Lundback. 2006. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 129: 879–885.CrossRefPubMed
8.
go back to reference Sopori, M. 2002. Effects of cigarette smoke on the immune system. Nature Reviews. Immunology 2: 372–377.CrossRefPubMed Sopori, M. 2002. Effects of cigarette smoke on the immune system. Nature Reviews. Immunology 2: 372–377.CrossRefPubMed
9.
go back to reference Culpitt, S.V., D.F. Rogers, P. Shah, et al. 2003. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 167: 24–31.CrossRefPubMed Culpitt, S.V., D.F. Rogers, P. Shah, et al. 2003. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 167: 24–31.CrossRefPubMed
10.
go back to reference Russell, R.E., S.V. Culpitt, C. DeMatos, et al. 2002. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 26: 602–609.CrossRefPubMed Russell, R.E., S.V. Culpitt, C. DeMatos, et al. 2002. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 26: 602–609.CrossRefPubMed
11.
go back to reference Aronoff, D.M., C. Lewis, C.H. Serezani, et al. 2009. E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection. Journal of Immunology (Baltimore, Md.: 1950) 183: 2642–2649.CrossRef Aronoff, D.M., C. Lewis, C.H. Serezani, et al. 2009. E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection. Journal of Immunology (Baltimore, Md.: 1950) 183: 2642–2649.CrossRef
12.
go back to reference Canning, B.J. 2003. Modeling asthma and COPD in animals: a pointless exercise? Current Opinion in Pharmacology 3: 244–250.CrossRefPubMed Canning, B.J. 2003. Modeling asthma and COPD in animals: a pointless exercise? Current Opinion in Pharmacology 3: 244–250.CrossRefPubMed
13.
go back to reference Gaziano, R., S. Bozza, S. Bellocchio, et al. 2004. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrobial Agents and Chemotherapy 48: 4414–4421.CrossRefPubMedPubMedCentral Gaziano, R., S. Bozza, S. Bellocchio, et al. 2004. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrobial Agents and Chemotherapy 48: 4414–4421.CrossRefPubMedPubMedCentral
14.
go back to reference Graybill, J.R., and S.R. Kaster. 1984. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. The American Review of Respiratory Disease 129: 292–295.PubMed Graybill, J.R., and S.R. Kaster. 1984. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. The American Review of Respiratory Disease 129: 292–295.PubMed
15.
go back to reference Luther, K., M. Rohde, J. Heesemann, and F. Ebel. 2006. Quantification of phagocytosis of Aspergillus conidia by macrophages using a novel antibody-independent assay. Journal of Microbiological Methods 66: 170–173.CrossRefPubMed Luther, K., M. Rohde, J. Heesemann, and F. Ebel. 2006. Quantification of phagocytosis of Aspergillus conidia by macrophages using a novel antibody-independent assay. Journal of Microbiological Methods 66: 170–173.CrossRefPubMed
16.
go back to reference Segal, B.H. 2007. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. The Oncologist 12(Suppl 2): 7–13.PubMed Segal, B.H. 2007. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. The Oncologist 12(Suppl 2): 7–13.PubMed
17.
go back to reference Hodge, S., G. Hodge, R. Scicchitano, P.N. Reynolds, and M. Holmes. 2003. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunology and Cell Biology 81: 289–296.CrossRefPubMed Hodge, S., G. Hodge, R. Scicchitano, P.N. Reynolds, and M. Holmes. 2003. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunology and Cell Biology 81: 289–296.CrossRefPubMed
18.
go back to reference Berenson, C.S., M.A. Garlipp, L.J. Grove, J. Maloney, and S. Sethi. 2006. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. The Journal of Infectious Diseases 194: 1375–1384.CrossRefPubMed Berenson, C.S., M.A. Garlipp, L.J. Grove, J. Maloney, and S. Sethi. 2006. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. The Journal of Infectious Diseases 194: 1375–1384.CrossRefPubMed
19.
go back to reference Sarir, H., E. Mortaz, K. Karimi, et al. 2009. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. Journal of Inflammation (London, England) 6: 12.CrossRef Sarir, H., E. Mortaz, K. Karimi, et al. 2009. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. Journal of Inflammation (London, England) 6: 12.CrossRef
20.
go back to reference Doz, E., N. Noulin, E. Boichot, et al. 2008. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. Journal of Immunology (Baltimore, Md.: 1950) 180: 1169–1178.CrossRef Doz, E., N. Noulin, E. Boichot, et al. 2008. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. Journal of Immunology (Baltimore, Md.: 1950) 180: 1169–1178.CrossRef
21.
go back to reference Grunig, G., D.B. Corry, M.W. Leach, B.W. Seymour, V.P. Kurup, and D.M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. The Journal of Experimental Medicine 185: 1089–1099.CrossRefPubMedPubMedCentral Grunig, G., D.B. Corry, M.W. Leach, B.W. Seymour, V.P. Kurup, and D.M. Rennick. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. The Journal of Experimental Medicine 185: 1089–1099.CrossRefPubMedPubMedCentral
22.
go back to reference Brown, G.D., P.R. Taylor, D.M. Reid, et al. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. The Journal of Experimental Medicine 196: 407–412.CrossRefPubMedPubMedCentral Brown, G.D., P.R. Taylor, D.M. Reid, et al. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. The Journal of Experimental Medicine 196: 407–412.CrossRefPubMedPubMedCentral
23.
go back to reference Mumby, P.J., J.R. Chisholm, C.D. Clark, J.D. Hedley, and J. Jaubert. 2001. Spectrographic imaging. A bird’s-eye view of the health of coral reefs. Nature 413: 36.CrossRefPubMed Mumby, P.J., J.R. Chisholm, C.D. Clark, J.D. Hedley, and J. Jaubert. 2001. Spectrographic imaging. A bird’s-eye view of the health of coral reefs. Nature 413: 36.CrossRefPubMed
24.
go back to reference Opitz, B., N.W. Schroder, I. Spreitzer, et al. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. The Journal of Biological Chemistry 276: 22041–22047.CrossRefPubMed Opitz, B., N.W. Schroder, I. Spreitzer, et al. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. The Journal of Biological Chemistry 276: 22041–22047.CrossRefPubMed
25.
go back to reference Mambula, S.S., K. Sau, P. Henneke, D.T. Golenbock, and S.M. Levitz. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. The Journal of Biological Chemistry 277: 39320–39326.CrossRefPubMed Mambula, S.S., K. Sau, P. Henneke, D.T. Golenbock, and S.M. Levitz. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. The Journal of Biological Chemistry 277: 39320–39326.CrossRefPubMed
26.
go back to reference Gantner, B.N., R.M. Simmons, S.J. Canavera, S. Akira, and D.M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. The Journal of Experimental Medicine 197: 1107–1117.CrossRefPubMedPubMedCentral Gantner, B.N., R.M. Simmons, S.J. Canavera, S. Akira, and D.M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. The Journal of Experimental Medicine 197: 1107–1117.CrossRefPubMedPubMedCentral
27.
go back to reference Wu, J., Y. Zhang, Z. Xin, and X. Wu. 2015. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis. Molecular Immunology 64: 235–243.CrossRefPubMed Wu, J., Y. Zhang, Z. Xin, and X. Wu. 2015. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis. Molecular Immunology 64: 235–243.CrossRefPubMed
28.
go back to reference Shen, Y., I. Kawamura, T. Nomura, et al. 2010. Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infection and Immunity 78: 2857–2867.CrossRefPubMedPubMedCentral Shen, Y., I. Kawamura, T. Nomura, et al. 2010. Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infection and Immunity 78: 2857–2867.CrossRefPubMedPubMedCentral
29.
go back to reference Kong, L., and B.X. Ge. 2008. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Research 18: 745–755.CrossRefPubMed Kong, L., and B.X. Ge. 2008. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Research 18: 745–755.CrossRefPubMed
Metadata
Title
Susceptibility to Aspergillus Infections in Rats with Chronic Obstructive Pulmonary Disease via Deficiency Function of Alveolar Macrophages and Impaired Activation of TLR2
Authors
Yuting Wu
Hong Xu
Li Li
Weifeng Yuan
Deming Zhang
Wenjie Huang
Publication date
01-08-2016
Publisher
Springer US
Published in
Inflammation / Issue 4/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0363-x

Other articles of this Issue 4/2016

Inflammation 4/2016 Go to the issue